Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Tissue "Hypoxia" and the Maintenance of Leukemia Stem Cells.

Dello Sbarba P, Cheloni G.

Adv Exp Med Biol. 2019;1143:129-145. doi: 10.1007/978-981-13-7342-8_6.

PMID:
31338818
2.

Intragenic antagonistic roles of protein and circRNA in tumorigenesis.

Guarnerio J, Zhang Y, Cheloni G, Panella R, Mae Katon J, Simpson M, Matsumoto A, Papa A, Loretelli C, Petri A, Kauppinen S, Garbutt C, Petur Nielsen G, Deshpande V, Castillo-Martin M, Cordon-Cardo C, Dimitrios S, Clohessy JG, Batish M, Pandolfi PP.

Cell Res. 2019 Aug;29(8):628-640. doi: 10.1038/s41422-019-0192-1. Epub 2019 Jun 17.

PMID:
31209250
3.

Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.

Mugoni V, Panella R, Cheloni G, Chen M, Pozdnyakova O, Stroopinsky D, Guarnerio J, Monteleone E, Lee JD, Mendez L, Menon AV, Aster JC, Lane AA, Stone RM, Galinsky I, Zamora JC, Lo-Coco F, Bhasin MK, Avigan D, Longo L, Clohessy JG, Pandolfi PP.

Cell Res. 2019 Jun;29(6):446-459. doi: 10.1038/s41422-019-0162-7. Epub 2019 Apr 25.

PMID:
31024166
4.

Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors.

4° JOINT MEETING OF PATHOLOGY AND LABORATORY MEDICINE SIPMET–SIPMEL - SECOND JOINT MEETING IN COLLABORATION WITH ASIP–AMP–UEMS–WASPALM - 4° SIPMEL NATIONAL CONGRESS - 34° SIPMET NATIONAL CONGRESS - 4° CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, Tusa I, Cheloni G, Poteti M, Gozzini A, Deng X, Gray NS, Li S, Dello Sbarba P, Rovida E.

J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4 Suppl. 1):36. No abstract available.

PMID:
30810012
5.

Species-species interactions modulate copper toxicity under different visible light conditions.

Cheloni G, Gagnaux V, Slaveykova VI.

Ecotoxicol Environ Saf. 2019 Apr 15;170:771-777. doi: 10.1016/j.ecoenv.2018.12.039. Epub 2018 Dec 26.

PMID:
30593990
6.

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells.

Tusa I, Cheloni G, Poteti M, Gozzini A, DeSouza NH, Shan Y, Deng X, Gray NS, Li S, Rovida E, Dello Sbarba P.

Stem Cell Reports. 2018 Oct 9;11(4):929-943. doi: 10.1016/j.stemcr.2018.08.016. Epub 2018 Sep 20.

7.

The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.

Cheloni G, Poteti M, Bono S, Masala E, Mazure NM, Rovida E, Lulli M, Dello Sbarba P.

Stem Cells Int. 2017;2017:4979474. doi: 10.1155/2017/4979474. Epub 2017 Jun 4.

8.

Tetraselmis suecica F&M-M33 growth is influenced by its associated bacteria.

Biondi N, Cheloni G, Rodolfi L, Viti C, Giovannetti L, Tredici MR.

Microb Biotechnol. 2018 Jan;11(1):211-223. doi: 10.1111/1751-7915.12865. Epub 2017 Nov 3.

9.

Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine.

Cheloni G, Tanturli M, Tusa I, Ho DeSouza N, Shan Y, Gozzini A, Mazurier F, Rovida E, Li S, Dello Sbarba P.

Blood. 2017 Aug 3;130(5):655-665. doi: 10.1182/blood-2016-10-745588. Epub 2017 Jun 2.

10.

Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.

Xie H, Peng C, Huang J, Li BE, Kim W, Smith EC, Fujiwara Y, Qi J, Cheloni G, Das PP, Nguyen M, Li S, Bradner JE, Orkin SH.

Cancer Discov. 2016 Nov;6(11):1237-1247. Epub 2016 Sep 14.

11.

The Culture Repopulation Ability (CRA) Assay and Incubation in Low Oxygen to Test Antileukemic Drugs on Imatinib-Resistant CML Stem-Like Cells.

Cheloni G, Tanturli M.

Methods Mol Biol. 2016;1465:73-85. doi: 10.1007/978-1-4939-4011-0_7.

PMID:
27581140
12.

Interactive effects of copper oxide nanoparticles and light to green alga Chlamydomonas reinhardtii.

Cheloni G, Marti E, Slaveykova VI.

Aquat Toxicol. 2016 Jan;170:120-128. doi: 10.1016/j.aquatox.2015.11.018. Epub 2015 Nov 23.

PMID:
26655656
13.

Salarin C inhibits the maintenance of chronic myeloid leukemia progenitor cells.

Del Poggetto E, Tanturli M, Ben-Califa N, Gozzini A, Tusa I, Cheloni G, Marzi I, Cipolleschi MG, Kashman Y, Neumann D, Rovida E, Dello Sbarba P.

Cell Cycle. 2015;14(19):3146-54. doi: 10.1080/15384101.2015.1078029.

14.

The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy.

Rovida E, Peppicelli S, Bono S, Bianchini F, Tusa I, Cheloni G, Marzi I, Cipolleschi MG, Calorini L, Sbarba PD.

Cell Cycle. 2014;13(20):3169-75. doi: 10.4161/15384101.2014.964107.

15.

Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.

Chen Y, Peng C, Abraham SA, Shan Y, Guo Z, Desouza N, Cheloni G, Li D, Holyoake TL, Li S.

J Clin Invest. 2014 Sep;124(9):3847-62. doi: 10.1172/JCI66129. Epub 2014 Aug 8.

16.

Antagonistic and synergistic effects of light irradiation on the effects of copper on Chlamydomonas reinhardtii.

Cheloni G, Cosio C, Slaveykova VI.

Aquat Toxicol. 2014 Oct;155:275-82. doi: 10.1016/j.aquatox.2014.07.010. Epub 2014 Jul 15.

PMID:
25072593
17.

Optimization of the C11-BODIPY(581/591) dye for the determination of lipid oxidation in Chlamydomonas reinhardtii by flow cytometry.

Cheloni G, Slaveykova VI.

Cytometry A. 2013 Oct;83(10):952-61. doi: 10.1002/cyto.a.22338. Epub 2013 Aug 13.

18.

Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.

Barbetti V, Gozzini A, Cheloni G, Marzi I, Fabiani E, Santini V, Dello Sbarba P, Rovida E.

Epigenetics. 2013 Feb;8(2):210-9. doi: 10.4161/epi.23538. Epub 2013 Jan 15. Erratum in: Epigenetics. 2013 Dec;8(12):1384.

Supplemental Content

Loading ...
Support Center